Literature DB >> 29177260

Radioiodine associated de novo Graves' opthalmopathy in an Asian cohort.

Wei Lin Tay1, Aaron Kian Ti Tong, Kei Yiu Douglas Hui, Yu Lin Charlene Tang, Chiaw Ling Chng.   

Abstract

Radioactive iodine in the treatment of Graves' disease has been associated with the development of de novo Graves' ophthalmopathy (GO). In this report, we describe five individuals who required extensive ophthalmic treatment for post-RAI de novo GO.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29177260     DOI: 10.1967/s002449910606

Source DB:  PubMed          Journal:  Hell J Nucl Med        ISSN: 1790-5427            Impact factor:   1.102


  2 in total

Review 1.  The risk factors for Graves' ophthalmopathy.

Authors:  Jiamin Cao; Yuhe Su; Zhuokun Chen; Chen Ma; Wei Xiong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-11-17       Impact factor: 3.117

2.  Severe radiation thyroiditis after radioactive iodine for treatment of Graves' disease.

Authors:  Wei Lin Tay; Lynette Mei Yee Lee; Aaron Kian Ti Tong; Chiaw Ling Chng
Journal:  Singapore Med J       Date:  2020-03-31       Impact factor: 3.331

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.